Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 455

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 455
---
2024, we funded our operations with $5,252,725 from the issuance of NLS Common Shares and preferred shares in private offerings and $173,123 from the exercise of pre -fundedwarrants. As of December31, 2024, we had $1,665,395 in cash and cash equivalents. The table below summarizes our cash flows for the years ended December31, 2024 and 2023:

|                                                      |     |   |       2024 |   |     |   |       2023 |   |
|:-----------------------------------------------------|:----|:--|-----------:|:--|:----|:--|-----------:|:--|
| Net cash used in operating activities                |     | $ | (4,267,884 | ) |     | $ | (9,684,466 | ) |
| Net cash used in investing activities                |     |   |     (3,917 | ) |     |   |          — |   |
| Net cash provided by financing activities            |     | $ |  5,039,516 |   |     | $ |  1,633,746 |   |
| Net increase (decrease) in cash and cash equivalents |     | $ |    767,715 |   |     | $ | (8,050,720 | ) |

Operating Activities Net cash used in operating activities was $4,267,884 during the year ended December31, 2024 compared with net cash used in operating activities of $9,684,466 for the year ended December31, 2023. The change in cash used in operating activities for the year ended December31, 2024 was due to our reporting a net loss of $1,980,810 for the year ended December31, 2024, compared with a net loss of $12,172,029 for the same period in 2023, driven mainly by a $7,426,950 decrease in total operating costs and a $2,499,969 increase in Other income due to the termination of EF Licensing Agreement for the year ended December31, 2024. Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through debt and/or equity financings. We cannot be certain that additional funding will be available to us on acceptable terms, if at all. This may raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments